Enavate Sciences GP
Latest statistics and disclosures from Enavate Sciences GP's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SION, ZBIO, IMNM, BBOT, CMPX, and represent 93.27% of Enavate Sciences GP's stock portfolio.
- Reduced shares in these 1 stock: CAMP.
- Enavate Sciences GP was a net seller of stock by $-3.3M.
- Enavate Sciences GP has $345M in assets under management (AUM), dropping by -1.74%.
- Central Index Key (CIK): 0001953107
Tip: Access up to 7 years of quarterly data
Positions held by Enavate Sciences GP consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Enavate Sciences GP
Enavate Sciences GP holds 7 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Sionna Therapeutics (SION) | 31.6 | $109M | 2.5M | 43.99 |
|
|
| Zenas Biopharma (ZBIO) | 28.8 | $100M | 3.9M | 25.38 |
|
|
| Immunome (IMNM) | 22.2 | $77M | 3.6M | 21.19 |
|
|
| Bridgebio Oncology Therapeut Com New (BBOT) | 5.8 | $20M | 2.6M | 7.62 |
|
|
| Compass Therapeutics (CMPX) | 4.9 | $17M | 7.8M | 2.19 |
|
|
| Upstream Bio (UPB) | 4.9 | $17M | 2.5M | 6.92 |
|
|
| Camp4 Therapeutics Corp (CAMP) | 1.8 | $6.2M | -34% | 1.4M | 4.37 |
|
Past Filings by Enavate Sciences GP
SEC 13F filings are viewable for Enavate Sciences GP going back to 2025
- Enavate Sciences GP 2026 Q2 filed Aug. 14, 2026
- Enavate Sciences GP 2026 Q1 filed May 15, 2026
- Enavate Sciences GP 2025 Q4 filed Feb. 17, 2026
- Enavate Sciences GP 2025 Q3 filed Nov. 14, 2025
- Enavate Sciences GP 2025 Q2 filed Aug. 14, 2025
- Enavate Sciences GP 2025 Q1 filed May 15, 2025